After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
TheStreet's Adam Feuerstein answers reader questions about biotech stocks.
Cramer is taking Honeywell over Boeing and is nervous about AIG.
Sure, we're in a bad moment but is it really worth ditching high-quality stocks to run for the hills? Cramer asks.
Trade-Ideas LLC identified Exelixis (EXEL) as a strong on high relative volume candidate
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.